Pembrolizumab plus lenvatinib for all advanced endometrial cancer? Maybe not

被引：1
作者：
Paulino, Eduardo [1 ]
机构：
[1] Brazilian Natl Canc Inst, BR-20081250 Rio De Janeiro, Brazil
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2022年 / 32卷 / 04期
关键词：
D O I：
10.1136/ijgc-2022-003419
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：579 / 579
页数：1
相关论文
共 5 条
  • [1] Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician's choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775)
    Colombo, N.
    Lorusso, D.
    Casado Herraez, A.
    Santin, A. D.
    Colomba, E.
    Miller, D. S.
    Fujiwara, K.
    Pignata, S.
    Floquet, A.
    Monk, B. J.
    Banerjee, S.
    Penson, R. T.
    Kristeleit, R.
    Fabbro, M.
    Orlando, M.
    Mackay, H.
    Jensen, E.
    Dutta, L.
    Orlowski, R.
    Makker, V.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S729 - S730
  • [2] Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
    Makker, V
    Colombo, N.
    Casado Herraez, A.
    Santin, A. D.
    Colomba, E.
    Miller, D. S.
    Fujiwara, K.
    Pignata, S.
    Baron-Hay, S.
    Ray-Coquard, I
    Shapira-Frommer, R.
    Ushijima, K.
    Sakata, J.
    Yonemori, K.
    Kim, Y. M.
    Guerra, E. M.
    Sanli, U. A.
    McCormack, M. M.
    Smith, A. D.
    Keefe, S.
    Bird, S.
    Dutta, L.
    Orlowski, R. J.
    Lorusso, D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05) : 437 - 448
  • [3] Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
    O'Malley, David M.
    Bariani, Giovanni Mendonca
    Cassier, Philippe A.
    Marabelle, Aurelien
    Hansen, Aaron R.
    Acosta, Ana De Jesus
    Miller, Wilson H., Jr.
    Safra, Tamar
    Italiano, Antoine
    Mileshkin, Linda
    Xu, Lei
    Jin, Fan
    Norwood, Kevin
    Maio, Michele
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (07) : 752 - 761
  • [4] Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
    Palma, David A.
    Olson, Robert
    Harrow, Stephen
    Gaede, Stewart
    Louie, Alexander V.
    Haasbeek, Cornelis
    Mulroy, Liam
    Lock, Michael
    Rodrigues, George B.
    Yaremko, Brian P.
    Schellenberg, Devin
    Ahmad, Belal
    Griffioen, Gwendolyn
    Senthi, Sashendra
    Swaminath, Anand
    Kopek, Neil
    Liu, Mitchell
    Moore, Karen
    Currie, Suzanne
    Bauman, Glenn S.
    Warner, Andrew
    Senan, Suresh
    [J]. LANCET, 2019, 393 (10185) : 2051 - 2058
  • [5] Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review
    van Weelden, Willem Jan
    Massuger, Leon F. A. G.
    Pijnenborg, Johanna M. A.
    Romano, Andrea
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
1